Kestra Medical Technologies, Ltd. (KMTS) Misses Q1 EPS by 19c, raises guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts KMTS Hot Sheet
Join SI Premium – FREE
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) reported Q1 EPS of ($0.61), $0.19 worse than the analyst estimate of ($0.42). Revenue for the quarter came in at $24.6 million, versus $0 reported last year.
GUIDANCE:
Kestra Medical Technologies, Ltd. sees FY2026 revenue of $93 million, versus the consensus of $90.936 million.
For earnings history and earnings-related data on Kestra Medical Technologies, Ltd. (KMTS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Updates US Conviction List Directors' Cut
- Oxford Square Capital Corp. (OXSQ) Misses Q3 EPS by 1c
- Stifel on FedEx Freight (FDXF): 'Enters Its Post-Breakup Era - Time to Hit the Gym and Focus on Itself'
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
